Newsletter
322 – BioTech Investment – AusBioInvest 2022 Feature Episode

Talking HealthTech

322 – BioTech Investment – AusBioInvest 2022 Feature Episode

January 16, 2023

322 – BioTech Investment – AusBioInvest 2022 Feature Episode

📺 Watch on YouTube:  https://www.youtube.com/watch?v=Wv7hOIKkcxc

The latest episode of Talking HealthTech features interviews with three industry leaders who appeared at the AusBioInvest 2022 event in Perth.

Dr Nilay Thakar, Principal of ARCH Venture Partners, delves into the mind of a venture capitalist and how to build an innovative biotech company. 

Dr Daniel Getts, Co-Founder and CEO of Myeloid Therapeutics, shares his insight into leveraging opportunities to accelerate innovation in Australia and the US. 

Finally, Dr Arjun Goyal, Co-Founder and Managing Director of Vida Ventures, talks about translating groundbreaking science into new medicines in the 21st century. 

Check out the episode and full show notes here.

Loving the show?  Leave us a review, and share it with someone who might get some value from it.

Keen to take your healthtech to the next level? Become a THT+ Member for access to our online community forum, quarterly summits and more exclusive content.  For more information visit here.

You may also like

Subscribe to Health Podcast Network

Join Our Newsletter

Proudly supported by:

cover
A Diverse Skill Set Peter McCanna is chief executive officer (CEO) at Baylor Scott & White Health, the largest not- for-profit health system in Texas. Through 51 hospitals and more than 1,200 access points, including flagship academic medical centers in Dallas, Fort Worth and Temple, the system offers the full continuum of care, from primary to award-winning specialty care, as well as an array of virtual and in-home services.